Dr. Jennifer Marie Reimer, DO

Dr. Reimer practices at Hmhmg Primary Care in Point Pleasant Beach, New Jersey.

Dr. Reimer's NPI, 1558651208, was assigned on April 14, 2011. Dr. Reimer graduated from New York College of Osteo Medicine of New York Institute of Technology in 2000. Dr. Reimer holds New Jersey license 25MB08918000.

Dr. Reimer's primary practice is Hmhmg Primary Care, at 800 State Rte 88, Point Pleasant Beach, NJ 08742 in Ocean County. The practice phone is (732) 807-0800.

Dr. Reimer's primary practice is Hmhmg Primary Care in Point Pleasant Beach, New Jersey. Dr. Reimer is also affiliated with Jersey Shore University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Reimer to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reimer practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Reimer's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Reimer is licensed in New Jersey.

CMS data shows 842 Medicare services from Dr. Reimer across 10 procedure codes in 2024, for 271 Medicare patients. Medicare paid $76,287 for them. Every service was in an office.

CMS counts 271 Medicare patients who saw Dr. Reimer in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reimer's median patient age at 62, with 75% women.

In 2024, Dr. Reimer wrote 4,807 Medicare Part D claims for 672 patients. 84% of them were for generic drugs. CMS names the drug for 4,140 of them, across 90 drugs with 11 or more claims each, at $493,945 in total drug cost. In 2023, CMS named 3,325 claims across 78 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Reimer for performance year 2024, reported through an alternative payment model (APM). Dr. Reimer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reimer as offering telehealth.

CMS Open Payments shows 719 general payments to Dr. Reimer from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,248.

Dr. Reimer graduated from New York College of Osteo Medicine of New York Institute of Technology in 2000.